title: Abnormal TNF-alpha production in diabetes-prone BB rats: enhanced TNF-alpha expression and defective PGE2 feedback inhibition.
abstract: Upon stimulation with lipopolysaccharide (LPS), peritoneal macrophages from diabetes-prone Bio-Breeding (BB) rats secrete more tumour necrosis factor-alpha (TNF-alpha) than macrophages from diabetes-resistant BB or normal Wistar rats. Enhanced transcription was demonstrated by Northern blot analysis and at the single cell level by mRNA: RNA hybridization. Cytofluorometry analysis showed 2-4 times more plasma membrane and total cell-associated TNF-alpha in macrophages of diabetes-prone BB rats. The analysis of fluorescence intensity showed a single peak, and TNF-alpha mRNA was found in > 90% of macrophages. These findings exclude TNF hypersecretion as being due to an abnormal subfraction of cells. TNF-alpha gene hyperexpression in diabetes-prone BB rats was not due to mutations in the regulatory regions of the promoter, which could be shown by cloning and sequencing of the TNF-alpha promoter in the three rat strains. When searching for other regulatory defects we found the production of prostaglandin E2 (PGE2) in response to LPS to be up to 10 times lower in macrophages from diabetes-prone BB rats than from Wistar rats. Furthermore, BB rats macrophages required significantly higher concentrations of PGE2 for suppression of TNF-alpha secretion. We conclude that abnormal TNF-alpha production in macrophages from diabetes-prone BB rats is due to enhanced gene transcription and translation and that this is associated with defective PGE2 feedback inhibition.
authors.affiliation: Diabetes Research Institute, Heinrich-Heine University, Düsseldorf, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Rothe
authors.forename: C
authors.initials: C
authors.lastname: Ongören
authors.forename: S
authors.initials: S
authors.lastname: Martin
authors.forename: P
authors.initials: P
authors.lastname: Rösen
authors.forename: H
authors.initials: H
authors.lastname: Kolb
mesh_terms: D000818:Animals; D001483:Base Sequence; D015152:Blotting, Northern; D002478:Cells, Cultured; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D015232:Dinoprostone / Q000502:physiology*; D005246:Feedback / Q000502:physiology; D015870:Gene Expression; D017403:In Situ Hybridization; D008264:Macrophages / Q000276:immunology; D008969:Molecular Sequence Data; D010529:Peritoneal Cavity / Q000166:cytology; D051381:Rats; D011913:Rats, Inbred BB; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D014409:Tumor Necrosis Factor-alpha; D015232:Dinoprostone